天美传媒

Abstract

The human microbiome, comprising diverse microbial communities residing in various body sites, influences health and disease through intricate interactions with the host. Recent advancements have elucidated its pivotal role in maintaining homeostasis and its dysregulation in disease states, prompting innovative strategies for therapeutic intervention. This abstract explores emerging approaches in microbiome-targeted therapies, including probiotics, prebiotics, fecal microbiota transplantation (FMT), microbial metabolites, and phage therapy. Key challenges such as standardization, safety, and regulatory considerations are discussed alongside opportunities in personalized medicine and microbiome engineering. Integrating microbiome data into clinical practice holds promise for revolutionizing disease treatment and prevention, leveraging insights into microbial community dynamics and host-microbe interactions. As research progresses, the potential of microbiome-targeted strategies to mitigate disease burden and enhance patient outcomes underscores their transformative impact on future healthcare paradigms.

The human microbiome, comprising trillions of microorganisms inhabiting our bodies, plays a crucial role in maintaining health and influencing disease. Recent advances in microbiome research have unveiled its intricate connection to various physiological processes and its potential as a therapeutic target for treating and preventing diseases. This article explores the evolving landscape of microbiome-targeted therapies, innovative strategies, challenges, and future directions in harnessing the microbiome for improving human health.